| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/13/2013 | CN102920673A Amorphous adefovir dipivoxil solid dispersion oral preparation and preparation method thereof |
| 02/13/2013 | CN102920672A Gatifloxacin dispersible tablet and preparation method thereof |
| 02/13/2013 | CN102920671A Cefmetazole sodium for injection |
| 02/13/2013 | CN102920666A Cefozopran hydrochloride freeze-dried powder |
| 02/13/2013 | CN102920663A Famciclovir sustained-release pellet, preparation method and application thereof |
| 02/13/2013 | CN102920662A Famciclovir sustained-release pellet, preparation method and application thereof |
| 02/13/2013 | CN102920656A Moxifloxacin nanoemulsion and its preparation method |
| 02/13/2013 | CN102920655A Florfenicol suspension injection and preparation procedure thereof |
| 02/13/2013 | CN102920641A Chinese medicinal foot bath powder as well as processing method and using method thereof |
| 02/13/2013 | CN102920635A Talcum powder capable of stopping bleeding, eliminate scars and resisting inflammation |
| 02/13/2013 | CN102920630A Tea component-containing bath preparation |
| 02/13/2013 | CN102920382A Cleaner towel capable of preventing hand-foot-mouth disease and preparation method of cleaner towel |
| 02/13/2013 | CN102920032A Socks for treating beriberi |
| 02/13/2013 | CN102919663A Preventing diseases in infants delivered via caesarean section |
| 02/13/2013 | CN102919269A Povidone-iodine disinfectant and preparation method thereof |
| 02/13/2013 | CN102525961B Powder injection of meropenem composition for injection |
| 02/13/2013 | CN102389385B Herba portulacae extract and solution, and preparation method and application |
| 02/13/2013 | CN102366479B Traditional Chinese medicinal foot-bath composition for treating beriberi |
| 02/13/2013 | CN102352365B Method for clearing away mycoplasma from pseudorabies vaccine strains |
| 02/13/2013 | CN102344914B Construction and application of recombinant MDV (Marek's Disease Virus) strain for expressing REV env (Reticuloendotheliosis Viruses envelope) |
| 02/13/2013 | CN102343088B Canine infectious tracheobronchitis bivalent live vaccine and preparation method thereof |
| 02/13/2013 | CN102327249B Lamivudine tablet composition and preparation method thereof |
| 02/13/2013 | CN102309463B Ganciclovir tablet composition and preparation method thereof |
| 02/13/2013 | CN102284061B Preparation method of heat-resisting vaccine for domestic animals |
| 02/13/2013 | CN102225146B Formula and production technology of traditional Chinese medicine injection for controlling bird flu |
| 02/13/2013 | CN102225077B Application of Chinese gall extract for controlling streptococcal disease in aquaculture animals |
| 02/13/2013 | CN102199489B Extraction method and formula of litsea cubeba compound essential oil |
| 02/13/2013 | CN102188687B Traditional Chinese medicine composition for treating cold |
| 02/13/2013 | CN102188591B Traditional Chinese medicine for treating colds and preparation method thereof |
| 02/13/2013 | CN102100911B Preparation method of Cynoglossus semilaevis vibrio anguillarum vaccine |
| 02/13/2013 | CN102038646B Sugar-free cefprozil dry suspension and preparation method thereof |
| 02/13/2013 | CN102028941B Neisseria meningitidis group B recombinant protein chimeric vaccine and preparation method thereof |
| 02/13/2013 | CN101993498B Adenovirus vector avian influenza recombinant vaccine |
| 02/13/2013 | CN101942417B Separated bacteriophages of enterobacter sakazakii, combination and application thereof |
| 02/13/2013 | CN101928253B 2-[5-(2-hydroxyphenyl]-4H-1,2,4-triazole-3-thioether]-1-acetophenone compound or pharmaceutically acceptable salt and preparation and application thereof |
| 02/13/2013 | CN101844994B Gossypol amino-acid derivative for blocking invasion of human immunodeficiency viruses and preparation method and application thereof |
| 02/13/2013 | CN101804090B Tablet used for treating prostate diseases as well as preparation method and application thereof |
| 02/13/2013 | CN101732707B Mercury-free Japanese encephalitis inactivated vaccine composition and application thereof |
| 02/13/2013 | CN101712594B 2-cyclohexyl-5-(1,1- dimethyl octyl) phenol and synthesizing method thereof |
| 02/13/2013 | CN101559223B Idemic encephalitis diphtheria-pertussis-tetanus combined vaccine |
| 02/13/2013 | CN101548683B Liquid disinfectant and method of producing the same |
| 02/13/2013 | CN101327201B Gossypol or liquid preparation of analogue thereof and preparation method and use thereof |
| 02/13/2013 | CN101100470B Tetranuclear bipyrane coumarin compound |
| 02/13/2013 | CN101072550B Stabilised oxygen releasing composition |
| 02/12/2013 | US8372968 RNA interference mediating small RNA molecules |
| 02/12/2013 | US8372958 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram posiive bacteria |
| 02/12/2013 | US8372852 Purines as reverse transcriptase inhibitors |
| 02/12/2013 | US8372413 Mycobacterial disease, malaria, leishmaniasis, toxoplasmosis, schistosomiasis and clonorchiasis; antiallergens; asthma |
| 02/12/2013 | US8372411 S. pneumoniae antigens |
| 02/12/2013 | US8372406 Antitumoral and antiviral peptides |
| 02/12/2013 | US8372404 Anti-C5/C5a antibodies and methods of use |
| 02/12/2013 | US8372401 Human antibodies that bind human TNFα |
| 02/12/2013 | US8372400 Methods of treating disorders using human antibodies that bind human TNFα |
| 02/12/2013 | US8372393 Method of inducing a CTL response |
| 02/12/2013 | CA2701768C Thiophene-2-carboxamide derivatives as modulators of ccr9 receptor |
| 02/12/2013 | CA2574464C Substituted quinolones |
| 02/12/2013 | CA2529817C Novel antibacterial agents |
| 02/12/2013 | CA2475310C Antimicrobial streptococcus salivarius strain and use thereof for preventing dental caries |
| 02/12/2013 | CA2469715C Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 02/12/2013 | CA2468892C Vitamin d analogues |
| 02/12/2013 | CA2462646C Adjuvanted meningococcus compositions |
| 02/12/2013 | CA2365903C Viral particles which are released after the infection with the human cytomegalovirus and the use of said particles as a vaccine |
| 02/12/2013 | CA2336250C Anti-ccr2 antibodies and methods of use therefor |
| 02/07/2013 | WO2013020074A2 A broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin |
| 02/07/2013 | WO2013020024A2 Maleimide compounds and methods of treatment |
| 02/07/2013 | WO2013019926A1 Treatment and prevention of diseases mediated by microorganisms via drug-mediated manipulation of the eicosanoid balance |
| 02/07/2013 | WO2013019828A1 Inhibitors of influenza viruses replication |
| 02/07/2013 | WO2013019669A2 Synthetic nanocarriers that generate humoral and cytotoxic t lymphocyte (ctl) immune responses |
| 02/07/2013 | WO2013019662A1 Aryl naphthalide lignans as anti-hiv agents |
| 02/07/2013 | WO2013019548A1 Hydrazide containing nuclear transport modulators and uses thereof |
| 02/07/2013 | WO2013018804A1 Uracil derivative and use thereof for medical purposes |
| 02/07/2013 | WO2013018735A1 Amidine compound or salt thereof |
| 02/07/2013 | WO2013018733A1 1,5-naphthyridine derivative or salt thereof |
| 02/07/2013 | WO2013018169A1 Antimicrobial activity enhancing agent |
| 02/07/2013 | WO2013017713A1 Hrsv f protein in the stabilised pre-fusion state and specific neutralising antibodies against same |
| 02/07/2013 | WO2013017653A1 Hcv immunotherapy |
| 02/07/2013 | WO2013017254A1 Oligosaccharides and oligosaccharide-protein conjugates derived from clostridium difficile polysaccaride ps-i, methods of synthesis and uses thereof, in particular as vaccines and diagnostic tools |
| 02/07/2013 | WO2013017026A1 Hcv protease inhibitors |
| 02/07/2013 | WO2013016805A1 Recombinant swine influenza virus and uses thereof |
| 02/07/2013 | US20130035397 Anti-Viral Compounds |
| 02/07/2013 | US20130035382 Anti-Viral Compounds |
| 02/07/2013 | US20130035381 Virus-inactivating composition containing low-molecular weight compound and arginine |
| 02/07/2013 | US20130035377 Tranylcypromine derivatives as inhibitors of histone demethylases lsd1 and/or lsd2 |
| 02/07/2013 | US20130035375 Gene re-cycling |
| 02/07/2013 | US20130035366 Modulation of hepatitis b virus (hbv) expression |
| 02/07/2013 | US20130035363 Thalidomide Analogs |
| 02/07/2013 | US20130035360 Novel water soluble furoxan derivatives having antitumor activity |
| 02/07/2013 | US20130035359 Compositions containing aromatic aldehydes and their use in treatments |
| 02/07/2013 | US20130035358 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 02/07/2013 | US20130035346 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors |
| 02/07/2013 | US20130035341 Macrocyclic integrase inhibitors |
| 02/07/2013 | US20130035328 Antiviral compounds and methods |
| 02/07/2013 | US20130035327 Modulators of ATP-Binding Cassette Transporters |
| 02/07/2013 | US20130035326 Biaryl compounds and methods of use thereof |
| 02/07/2013 | US20130035325 Kinase inhibitors |
| 02/07/2013 | US20130035318 C-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity |
| 02/07/2013 | US20130035313 Nucleoside Phosphonate Salts |
| 02/07/2013 | US20130035306 Process for preparing purine nucleosides |
| 02/07/2013 | US20130035299 Antimicrobial composition based on botanical extracts from oil palm vegetation liquor |
| 02/07/2013 | US20130035296 Therapeutic peptides |